INT J EQUITY HEALTH 润色咨询

International Journal for Equity in Health

出版年份：暂无数据 年文章数：1835 投稿命中率： 开通期刊会员，数据随心看

出版周期：暂无数据 自引率：暂无数据 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2187207, encodeId=32b2218e207ad, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向：卫生资源;公共卫生;社会医学<br>经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=654a9173497, createdName=ms1000002044867821, createdTime=Tue Feb 13 23:01:02 CST 2024, time=2024-02-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108533, encodeId=5fc1110853305, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108534, encodeId=e82c110853460, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572881, encodeId=96405e28810a, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：2018年已经涨到2.5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6f1108234, createdName=SAYID, createdTime=Mon Jun 24 11:03:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2024-02-13 ms1000002044867821 来自浙江省

    审稿速度:3.0 | 投稿命中率:95.0
    偏重的研究方向：卫生资源;公共卫生;社会医学
    经验分享：1

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2187207, encodeId=32b2218e207ad, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向：卫生资源;公共卫生;社会医学<br>经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=654a9173497, createdName=ms1000002044867821, createdTime=Tue Feb 13 23:01:02 CST 2024, time=2024-02-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108533, encodeId=5fc1110853305, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108534, encodeId=e82c110853460, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572881, encodeId=96405e28810a, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：2018年已经涨到2.5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6f1108234, createdName=SAYID, createdTime=Mon Jun 24 11:03:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2021-12-29 MS68862005

    Graphicalabstract是什么？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2187207, encodeId=32b2218e207ad, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向：卫生资源;公共卫生;社会医学<br>经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=654a9173497, createdName=ms1000002044867821, createdTime=Tue Feb 13 23:01:02 CST 2024, time=2024-02-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108533, encodeId=5fc1110853305, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108534, encodeId=e82c110853460, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572881, encodeId=96405e28810a, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：2018年已经涨到2.5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6f1108234, createdName=SAYID, createdTime=Mon Jun 24 11:03:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2021-12-27 学医的彭于晏

    投稿中一定要有Graphicalabstract么？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2187207, encodeId=32b2218e207ad, content=审稿速度:3.0 | 投稿命中率:95.0<br>偏重的研究方向：卫生资源;公共卫生;社会医学<br>经验分享：1, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=654a9173497, createdName=ms1000002044867821, createdTime=Tue Feb 13 23:01:02 CST 2024, time=2024-02-13, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1108533, encodeId=5fc1110853305, content=Graphicalabstract是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=39, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:53 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1108534, encodeId=e82c110853460, content=投稿中一定要有Graphicalabstract么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Mon Dec 27 14:52:53 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=572881, encodeId=96405e28810a, content=审稿速度:3.0 | 投稿命中率:25.0<br>经验分享：2018年已经涨到2.5, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b6f1108234, createdName=SAYID, createdTime=Mon Jun 24 11:03:00 CST 2019, time=2019-06-24, status=1, ipAttribution=)]
    2019-06-24 SAYID

    审稿速度:3.0 | 投稿命中率:25.0
    经验分享：2018年已经涨到2.5

    0

共6条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分